Pfizer (PFE) Offers 6.9% Dividend Yield Amid New Drug Development

Pfizer (PFE) has been identified as a solid dividend stock, currently offering a forward-looking dividend yield of 6.9%. The company is focused on developing new profit centers, including acquiring Seagen in 2023 to enhance its oncology pipeline. By 2030, Pfizer anticipates launching at least eight new blockbuster drugs, supported by both acquisitions and internal development. This potential for new drugs reinforces Pfizer's ability to continue providing dividends, which is important for investors seeking steady income.